Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization- a correlative study with urine PCA3 and TMPRSS2-ERG

被引:26
|
作者
Warrick, Joshua I. [1 ]
Tomlins, Scott A. [1 ,2 ,3 ,4 ]
Carskadon, Shannon L. [1 ,2 ]
Young, Allison M. [1 ]
Siddiqui, Javed [1 ,2 ]
Wei, John T. [4 ]
Chinnaiyan, Arul M. [1 ,2 ,3 ,4 ,5 ]
Kunju, Lakshmi P. [1 ,2 ,3 ]
Palanisamy, Nallasivam [1 ,2 ,3 ]
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48104 USA
[2] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI USA
[3] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA
[4] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA
[5] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
PCA3; prostate cancer; RNA in situ hybridization; ANTIBODY-BASED DETECTION; ETS GENE FUSIONS; INTRAEPITHELIAL NEOPLASIA; ANTIGEN; REARRANGEMENT STATUS; TMPRSS2/ERG; CARCINOMA; DD3;
D O I
10.1038/modpathol.2013.169
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
PCA3 is a prostate-specific non-coding RNA, with utility as a urine-based early detection biomarker. Here, we report the evaluation of tissue PCA3 expression by RNA in situ hybridization in a cohort of 41 mapped prostatectomy specimens. We compared tissue PCA3 expression with tissue level ERG expression and matched pre-prostatectomy urine PCA3 and TMPRSS2-ERG levels. Across 136 slides containing 138 foci of prostate cancer, PCA3 was expressed in 55% of cancer foci and 71% of high-grade prostatic intraepithelial neoplasia foci. Overall, the specificity of tissue PCA3 was >90% for prostate cancer and high-grade prostatic intraepithelial neoplasia combined. Tissue PCA3 cancer expression was not significantly associated with urine PCA3 expression. PCA3 and ERG positivity in cancer foci was positively associated (P<0.01). We report the first comprehensive assessment of PCA3 expression in prostatectomy specimens, and find limited correlation between tissue PCA3 and matched urine in prostate cancer.
引用
收藏
页码:609 / 620
页数:12
相关论文
共 50 条
  • [21] PCA3: A molecular urine prostate cancer test
    Rittenhouse, Harry
    TUMOR BIOLOGY, 2007, 28 : 50 - 50
  • [22] Urine PCA3 and TMPRSS2: ERG Using Cancer-specific Markers to Detect Cancer
    Tomlins, Scott A.
    EUROPEAN UROLOGY, 2014, 65 (03) : 543 - 545
  • [23] Evaluation of Tissue PCA3 Expression by RNA In-Situ Hybridization in Prostate Core Biopsies Including Diagnostically Challenging Cases
    Yoon, J. Y.
    Carskadon, S.
    Warrick, J. I.
    Siddiqui, J.
    Wei, J.
    Tomlins, S. A.
    Chinnaiyan, A.
    Palanisamy, N.
    Kunju, L. P.
    MODERN PATHOLOGY, 2014, 27 : 271A - 271A
  • [24] Evaluation of Tissue PCA3 Expression by RNA In-Situ Hybridization in Prostate Core Biopsies Including Diagnostically Challenging Cases
    Yoon, J. Y.
    Carskadon, S.
    Warrick, J. I.
    Siddiqui, J.
    Wei, J.
    Tomlins, S. A.
    Chinnaiyan, A.
    Palanisamy, N.
    Kunju, L. P.
    LABORATORY INVESTIGATION, 2014, 94 : 271A - 271A
  • [25] PCA3 and TMPRSS2 Gene Fusion Markers for Prostate Cancer
    Rittenhouse, Harry
    TUMOR BIOLOGY, 2008, 29 : 29 - 29
  • [26] Function of PCA3 in prostate tissue and clinical research progress on developing a PCA3 score
    Wang, Yue
    Liu, Xiao-Jun
    Yao, Xu-Dong
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (04) : 493 - 500
  • [27] Function of PCA3 in prostate tissue and clinical research progress on developing a PCA3 score
    Yue Wang
    Xiao-Jun Liu
    Xu-Dong Yao
    Chinese Journal of Cancer Research, 2014, 26 (04) : 493 - 500
  • [28] Association Between Combined TMPRSS2: ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer
    Sanda, Martin G.
    Feng, Ziding
    Howard, David H.
    Tomlins, Scott A.
    Sokoll, Lori J.
    Chan, Daniel W.
    Regan, Meredith M.
    Groskopf, Jack
    Chipman, Jonathan
    Patil, Dattatraya H.
    Salami, Simpa S.
    Scherr, Douglas S.
    Kagan, Jacob
    Srivastava, Sudhir
    Thompson, Ian M., Jr.
    Siddiqui, Javed
    Fan, Jing
    Joon, Aron Y.
    Bantis, Leonidas E.
    Rubin, Mark A.
    Chinnayian, Arul M.
    Wei, John T.
    JAMA ONCOLOGY, 2017, 3 (08) : 1085 - 1093
  • [29] RATIONAL BASIS FOR THE COMBINATION OF PCA3 AND TMPRSS2: ERG GENE FUSION IN PROSTATE CANCER DIAGNOSIS
    Robert, Gregoire
    Jannink, Sander
    Aalders, Tilly
    Mulders, Peter
    Schalken, Jack
    JOURNAL OF UROLOGY, 2011, 185 (04): : E648 - E648
  • [30] Specificity of PCA3 molecular urine test for prostate cancer
    Groskopf, J.
    Deras, I.
    Walker, S.
    Blase, A.
    Desaulniers, M.
    Fradet, Y.
    Marks, L. S.
    Rittenhouse, H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (05): : 665 - 666